CholesterolClinical TrialsDrugs (Pharmaceuticals)HeartKrumholz, Harlan MMaron, David JNovartis AGStroke

The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists

OMEGAZEPRIME News
This story was selected and curated by our editorial team in the Cholesterol category. Published on September 4, 2026 • Originally reported by Gina Kolata. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
OMEGAZEPRIME News — For more stories and analysis, visit omegazeprime.com

SUPPORT OMEGAZEPRIME

Help us keep delivering breaking news and world updates.

PayPalShop OMEGAZEPIX